Scilex Holding (SCLX) Current Assets (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Current Assets of $42.0 million for Q1 2026, up 46.22% year-over-year from $28.7 million in Q1 2025, and up 9.42% on a QoQ basis from $38.4 million in Q4 2025.

Scilex Holding (SCLX) Current Assets (2020 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Current Assets for 7 consecutive years, with $42.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Current Assets rose 46.22% year-over-year to $42.0 million; the TTM figure through Mar 2026 stood at $42.0 million (up 46.22% YoY), while the FY2025 annual figure was $38.4 million, down 7.68% from the prior year.
  • Current Assets came in at $42.0 million for Q1 2026 at Scilex Holding, up from $38.4 million in the prior quarter.
  • The five-year high for Current Assets was $69.2 million in Q2 2023, with the low at $165749.0 in Q3 2022.
  • Average Current Assets over 5 years is $31.3 million, with a median of $33.7 million recorded in 2025.
  • Across the five-year window, Current Assets jumped 15273.25% in 2023 and tumbled 58.63% in 2025, its largest moves.
  • Year by year, Current Assets stood at $29.6 million in 2022, then surged by 58.0% to $46.8 million in 2023, then decreased by 11.19% to $41.5 million in 2024, then dropped by 7.68% to $38.4 million in 2025, then increased by 9.42% to $42.0 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods registered $42.0 million, $38.4 million, and $16.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 54.84 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 59.17 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 33.53 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 29.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 35.02 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 31.48 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 18.64 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 42.82 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn 41.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 41.97 Mn
Dec 31, 2025 38.36 Mn
Sep 30, 2025 16.49 Mn
Jun 30, 2025 33.67 Mn
Mar 31, 2025 28.70 Mn
Dec 31, 2024 41.55 Mn
Sep 30, 2024 39.86 Mn
Jun 30, 2024 50.42 Mn
Mar 31, 2024 37.75 Mn
Dec 31, 2023 46.78 Mn
Sep 30, 2023 25.48 Mn
Jun 30, 2023 69.25 Mn
Mar 31, 2023 31.10 Mn
Dec 31, 2022 29.61 Mn
Sep 30, 2022 165,749.00
Jun 30, 2022 612,848.00
Mar 31, 2022 524,341.00
Dec 31, 2021 23.00 Mn
Sep 30, 2021 232,178.00
Jun 30, 2021 491,980.00